Trial Profile
Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2023
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 02 Dec 2021 Status changed from active, no longer recruiting to completed.
- 15 May 2019 Planned End Date changed from 1 Oct 2019 to 1 Dec 2019.
- 15 May 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Aug 2019.